Healthequity Historical Valuation

HQY
 Stock
  

USD 66.75  0.06  0.09%   

Some fundamental drivers such as market cap or Healthequity enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze Healthequity valuation indicators such as Average Assets of 3.4 B or Earnings Before Interest Taxes and Depreciation Amortization EBITDA of 95.1 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of Healthequity's future value. Financial Statement Analysis is much more than just reviewing and breaking down Healthequity prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Healthequity is a good buy for the upcoming year.
Please check Risk vs Return Analysis.
  
Refresh
Share

About Healthequity Valuation Data Analysis

Valuation is the financial process of determining what Healthequity is worth. Healthequity valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. Healthequity valuation ratios help investors to determine whether Healthequity Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Healthequity with respect to the benefits of owning Healthequity security.

Healthequity Valuation Data Chart

Healthequity valuation ratios help to determine how cheap or expensive it is, compared to its peers or based on some benchmark measure of value for a given date. A typical valuation ratio shows the difference between the cost of Healthequity equity instrument and the benefits of owning shares of Healthequity.
Healthequity Net Income Per Employee is fairly stable at the moment as compared to the past year. Healthequity reported Net Income Per Employee of 2,609 in 2021. Average Assets is likely to rise to about 3.4 B in 2022, whereas Revenue Per Employee is likely to drop slightly above 201.2 K in 2022.

Average Assets

Average asset value for the period used in calculation of Return on Average Equity and Return on Average Assets; derived from Total Assets.

Enterprise Value

Enterprise Value (or EV) is usually referred to as Healthequity theoretical takeover price. In the event of an acquisition, an acquirer would have to take on Healthequity debt, but would also pocket its cash. Enterprise Value is more accurate representation of Healthequity value than its market capitalization because it takes into account all of Healthequity existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as Market Capitalization plus Total Debt USD minus Cash and Equivalents USD.

Market Capitalization

Market capitalization (or market cap) is the total value of the shares outstanding of Healthequity. It is equal to Healthequity current share price times the number of Healthequity outstanding shares. Represents the product of [SharesBas]; [Price] and [ShareFactor].
Most indicators from Healthequity valuation accounts are interrelated and interconnected. However, analyzing valuation accounts indicators one by one will only give a small insight into Healthequity current financial condition. On the other hand, looking into the entire matrix of valuation accounts indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please check Risk vs Return Analysis.Healthequity Net Income Per Employee is fairly stable at the moment as compared to the past year. Healthequity reported Net Income Per Employee of 2,609 in 2021. Average Assets is likely to rise to about 3.4 B in 2022, whereas Revenue Per Employee is likely to drop slightly above 201.2 K in 2022.
 2019 2020 2021 2022 (projected)
Revenue Per Employee181.51 K240.73 K216.65 K201.18 K
Net Income Per Employee13.53 K2.9 K2.61 K2.68 K

Healthequity valuation accounts Correlations

Healthequity Account Relationship Matchups

Healthequity valuation accounts Accounts

201720182019202020212022 (projected)
Net Income Per Employee46.12 K64.77 K13.53 K2.9 K2.61 K2.68 K
Revenue Per Employee223.49 K251.75 K181.51 K240.73 K216.65 K201.18 K
Average Assets339.77 M465.09 M1.7 B2.65 B3.13 B3.38 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA68.42 M94.27 M123.28 M154.93 M107.02 M95.14 M
Earnings Before Interest Taxes and Depreciation Amortization USD68.42 M94.27 M123.28 M154.93 M107.02 M95.14 M
Earnings before Tax52.19 M75.82 M43.16 M4.14 M(66.74 M)(68.5 M)
Average Equity321.87 M440.87 M898.6 M1.28 B1.86 B2.01 B
Enterprise Value2.89 B3.6 B5.82 B7.22 B4.83 B4.65 B
Free Cash Flow65.86 M99.58 M72.07 M117.03 M69.38 M65.61 M
Invested Capital60.91 M35.17 M1.41 B1.16 B1.12 B1.21 B
Invested Capital Average65.25 M73.75 M804.95 M1.26 B1.14 B1.23 B
Market Capitalization3.07 B3.89 B4.68 B6.43 B4.47 B4.35 B
Tangible Asset Value280.87 M425.7 M449.07 M616.21 M488.13 M418.34 M
Working Capital244.91 M365.62 M145.36 M255.48 M198.15 M200.56 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Healthequity without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Channel Index Now

   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Risk vs Return Analysis. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.6 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.